Clinical Trial Update: A Healthy Volunteer Study to Assess the Relative Bioavailability of 2 Forms of SB773812 Tablets. [Phase 1]

View source ↗

Summary

Phase 1 healthy-volunteer study comparing the relative bioavailability of two tablet forms of SB773812, sponsored by GlaxoSmithKline, in the context of schizoph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• SB773812 (SB-773812)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED